Literature DB >> 709549

Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.

H J Wallace, M M Hreshchyshyn, G D Wilbanks, R C Boronow, W C Fowler, J A Blessing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709549

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

Review 1.  Chemotherapy for advanced or recurrent carcinoma of the cervix.

Authors:  J D Bloss
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 2.  Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.

Authors:  Krishnansu S Tewari; Bradley J Monk
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

Review 3.  Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.

Authors:  George A Omura
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

Review 4.  Taxanes: their impact on gynecologic malignancy.

Authors:  Carlton L Schwab; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Anticancer Drugs       Date:  2014-05       Impact factor: 2.248

5.  Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

Authors:  W P McGuire; J A Blessing; E Yordan; J Beecham
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

6.  Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.

Authors:  H J LONG; H S Wieand; J F Foley; R D Niedringhaus; J A Laurie; R F Morton; R M Goldberg; J A Mailliard; G D Malkasian; J H Edmonson
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

7.  A Clinicopathological Review of Pulmonary Metastasis from Uterine Cervical Cancer.

Authors:  Eun Young Ki; Keun Ho Lee; Jong Sup Park; Soo Young Hur
Journal:  Cancer Res Treat       Date:  2015-02-23       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.